Insider Transactions in Q1 2025 at Precision Biosciences Inc (DTIL)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 22
2025
|
J. Jefferson Smith Chief Research Officer |
SELL
Open market or private sale
|
Direct |
10,287
-10.53%
|
$41,148
$4.79 P/Share
|
|
Jan 22
2025
|
Dario Scimeca General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
8,928
-26.83%
|
$35,712
$4.79 P/Share
|
|
Jan 21
2025
|
Michael Amoroso President and CEO |
SELL
Open market or private sale
|
Direct |
36,838
-25.6%
|
$147,352
$4.67 P/Share
|
|
Jan 20
2025
|
J. Jefferson Smith Chief Research Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
29,168
+22.99%
|
-
|
|
Jan 20
2025
|
Michael Amoroso President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
115,388
+44.5%
|
-
|
|
Jan 20
2025
|
John Alexander Kelly Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
44,368
+34.41%
|
-
|
|
Jan 20
2025
|
Dario Scimeca General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
25,312
+43.2%
|
-
|